Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Long-term treatment of chronic hepatitis C with ursodeoxycholic acid: influence of HCV genotypes and severity of liver disease.

Liver - 1 Oct 1999

Lirussi F, Beccarello A, Bortolato L, Morselli-Labate A M, Crovatto M, Ceselli S, Santini G, Crepaldi G

Abstract excerpt

AIMS/BACKGROUND: Current therapy for chronic hepatitis C virus (HCV) infection is based on the administration of interferon alpha (IFN) alone or in combination with other anti-viral agents. However, such therapy is effective in only a minority of selected patients. Long-term ursodeoxycholic acid (UDCA) treatment has been reported to improve liver function and structure especially in cholestatic disorders. We...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alanine Transaminase
Share to Aspartate Aminotransferases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to gamma-Glutamyltransferase

Share to Hepatitis C Antibodies

Share to Hepatitis C, Chronic

Share to Liver Cirrhosis

Share to Liver Function Tests

Share to Ursodeoxycholic Acid

Source

Identifiers

PMID: 10533795
DOI: 10.1111/j.1478-3231.1999.tb00066.x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 8 closest

Long-term treatment of chronic hepatitis C with ursodeoxycholic acid: influence of HCV genotypes and severity of liver disease.PMID 10533795Read ↗

Long-term administration of natural interferon-alpha in patients with chronic hepatitis C: relationship to serum RNA concentration, HCV-RNA genotypes, histological changes and hepatitis C virus.Semantic proximity Read ↗

Histological features of chronic hepatitis C in haemodialysis patients.Semantic proximity Read ↗

A comparison of genotype and markers of disease severity of chronic hepatitis C in patients with and without end-stage renal disease.Semantic proximity Read ↗

Increased levels of gammaGT suggest the presence of bile duct lesions in patients with chronic hepatitis C: absence of influence of HCV genotype, HCV-RNA serum levels, and HGV infection on this histological damage.Semantic proximity Read ↗

Impact of hepatitis C virus duration and hepatitis C virus genotypes on renal transplant patients: correlation with clinicopathological features.Semantic proximity Read ↗

Ribavirin treatment for patients with chronic hepatitis C: results of a placebo-controlled study.Semantic proximity Read ↗

The clinical value of grading and staging scores for predicting a long-term response and evaluating the efficacy of interferon therapy in chronic hepatitis C.Semantic proximity Read ↗

Determination of the cut-off value of serum alanine aminotransferase in patients undergoing hemodialysis, to identify biochemical activity in patients with hepatitis C viremia.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.